Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 16Thoracic 4Head & Neck 4Other solid neoplasm 3Gastrointestinal 3Breast 3Tumor-Agnostic 2Other neoplasm 2Dermatologic 2Sarcoma 1Other hematologic neoplasm 1Other 1Lymphoid 1CNS 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 3

Interventions

Cisplatin 145pembrolizumab 129Carboplatin 125Injections 108Pemetrexed 97Paclitaxel 97Gemcitabine 85Irinotecan 75Nivolumab 71Cyclophosphamide 71Docetaxel 68Bevacizumab 57Oxaliplatin 49Fluorouracil 48atezolizumab 46Capecitabine 46Etoposide 42Leucovorin 41tislelizumab 40toripalimab 36fludarabine 32Ipilimumab 30Drug Therapy 30Topotecan 29durvalumab 28Vincristine 27Early Intervention, Educational 27Radiotherapy 26Interviews as Topic 26Specimen Handling 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Calcitriol × Other solid neoplasm × Clear all
NCT00084708 2014-01-13

Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors

Roswell Park Cancer Institute

Phase 1 Completed
53 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00009802 2013-12-19

Calcitriol Plus Paclitaxel in Treating Patients With Advanced Solid Tumors

University of Pittsburgh

Phase 1 Completed
45 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00238225 2013-01-31

Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors

Roswell Park Cancer Institute

Phase 1 Completed
15 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡